Current Opinion in Rheumatology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Rheumatology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
W. Joseph McCune
Following Residency at the University of Michigan, and Fellowship at the Brigham and Women's Hospital, Dr W. Joseph McCune joined the faculty of the University of Michigan, USA, where he is the Michael and Marcia Klein Professor of Rheumatic Diseases and Director of the Lupus Program. His research focuses on the epidemiology, diagnosis, and therapy of systemic lupus and systemic vasculitis including immunosuppression in systemic lupus erythematosus (SLE), the pathogenesis of cardiovascular disease in SLE, and imaging in neuropsychiatric lupus.
Jon T. Giles
Dr Jon T. Giles is the Associate Professor of Medicine at the College of Physicians & Surgeons in Columbia University, USA. His research interests are centered primarily within the inflammatory arthritides. His current projects center around understanding the inflammatory and non-inflammatory determinants of body composition abnormalities in rheumatoid arthritis and psoriatic arthritis, and their subsequent effects on health outcomes. Other current and past research involves the investigation of accelerated atherosclerosis and myocardial dysfunction in rheumatoid arthritis patients, understanding the determinants of rheumatoid arthritis-associated interstitial lung disease, and exploring the musculoskeletal side-effects of a class of medications used to suppress estrogen in women with certain forms of breast cancer. He is the recipient of grant support from the National Institutes of Health, the Arthritis Foundation, the Rheumatology Research Foundation, the Marianne Legato Foundation, and the Arthritis National Research Foundation.